Jundishapur Journal of Microbiology

Published by: Kowsar

Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination

Ahmad Shamsizadeh 1 , 2 , Roya Nikfar 2 , * , Manoochehr Makvandi 1 , Makvandi Hakimzadeh 2 , Mohsen Alisamir 2 and Tahereh Ziaei 2
Authors Information
1 Jundishapur Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Abuzar Children’s Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: September 01, 2012, 5 (4); 578-581
  • Published Online: September 8, 2012
  • Article Type: Research Article
  • Received: February 2, 2012
  • Revised: February 20, 2012
  • Accepted: February 22, 2012
  • DOI: 10.5812/jjm.4563

To Cite: Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, et al. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination, Jundishapur J Microbiol. 2012 ; 5(4):578-581. doi: 10.5812/jjm.4563.

Abstract
Copyright © 2012, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Gabutti G, Rota MC, Salmaso S, Bruzzone BM, Bella A, Crovari P. Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect. 2002; 129(3): 543-50[DOI]
  • 2. Litman N, Baum S. Douglas and Bennett’s Principles and Practice of Infectious Diseases. Mumps virus. 2010; : 2201-6[DOI]
  • 3. Cherry J. Feigin and cherry’s Textbook of pediatric Infectious Diseases. 2009; : 2271-300
  • 4. Yadav S, Thukral R, Chakarvarti A. Comparative evaluation of measles, mumps and rubella vaccine at 9 and 15 months of age. Indian J Med Res. 2003; 118: 183-6[PubMed]
  • 5. Schedule and guideline of immunization. 1999;
  • 6. Schedule and guideline of immunization. 2005;
  • 7. Schedule and guideline of immunization. 2009;
  • 8. Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, et al. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age. Vaccine. 2009; 27(20): 2701-6[DOI][PubMed]
  • 9. Raut SK, Kulkarni PS, Phadke MA, Jadhav SS, Kapre SV, Dhere RM, et al. Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India. Clin Vaccine Immunol. 2007; 14(10): 1370-1[DOI][PubMed]
  • 10. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. J Infect Dis. 2004; 189-22[DOI][PubMed]
  • 11. Vesikari T, Baer M, Willems P. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Pediatr Infect Dis J. 2007; 26(2): 153-8[DOI][PubMed]
  • 12. Yalcin SS, Kanra G, Pehlivan T. Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses. Int J Adolesc Med Health. 2006;18 (4):615-22.; 2006(4): 615-22[DOI]
  • 13. Dominguez A, Torner N, Castilla J, Batalla J, Godoy P, Guevara M, et al. Mumps vaccine effectiveness in highly immunized populations. Vaccine. 2010; 28(20): 3567-70[DOI][PubMed]
  • 14. Fylaktou A, Haidopoulou K, Goutaki M, Papadimitriou E, Kalamitsiou S, Papaventsis D. Measles and mumps immunity in Northern Greece, 2004-2007. Euro Surveill. 2008; 13(16)[PubMed]
  • 15. Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect. 2004; 132(1): 11-8[DOI][PubMed]
  • 16. Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine. 2002; 20(7-8): 1134-40[DOI]
  • 17. Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J. 2008; 27(8): 724-30[DOI][PubMed]
  • 18. Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme. J Health Popul Nutr. 2009; 27(1): 80-6[DOI]
  • 19. Jaber SM. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Saudi Med J. 2006; 27(1): 63[PubMed]
  • 20. Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J. 1996; 15(8): 687-92[DOI][PubMed]
  • 21. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine. 1995; 13(9): 799-802[DOI]
  • 22. Loo MK, Sabahi F, Soleimanjdahi H, Kazemnejad A, Roustai MH. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998. Eur J Epidemiol. 2003; 18(11): 1085-9[DOI]
  • 23. Gurgoze MK, Yilmaz E, Godekmerdan A, Akca Z, Dogan Y, Akarsu S, et al. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey. Turk J Pediatr. 2006; 48(3): 185-8[PubMed]
  • 24. Muhsen K, Aboudy Y, Mendelson E, Green MS, Cohen D. Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease. Epidemiol Infect. 2008; 136(5): 688-93[DOI][PubMed]
  • 25. Gaafar T, Moshni E, Lievano F. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010. J Infect Dis. 2003; 187-71[DOI][PubMed]
  • 26. Izadi S, Zahraei SM, Sartipi M. An investigation into a measles outbreak in southeast Iran. Jpn J Infect Dis. 2012; 65(1): 45-51[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments